1Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics,2002 [ J].CA Cancer J Clin,2005,55(2) :74-108.
2Saka M,Katai H,Fukagawa T,et al. Recurrence in early gastric cancerwith lymphnode metastasis [ J]. Gastric Cancer, 2008,11 (4): 214-218.
3Miki K. Gastric cancer screening using the serum pepsinogen testmethod[ J]. Gastric Cancer,2006,9(4) :245-253.
4Miki K,Fujishiro M,Kodashima S,et al. Long-term results of gastriccancer screening using the serum pepsinogen test method among an a-symptomatic middle-aged Japanese population[ J]. Dig Endosc,2009,21(2):78-81.
5Inoue M,Tsugane S. Epidemiology of gastric cancer in Japan[ J]. Post-grad Med J,2005,81 (2) :419-424.
10Kim HY,Kim N,Kang JM,et al. Clinical meaning of pepsinogen testand Helicobacterpylori serology in the health check-up population inKorea[ J]. Eur J Gastroenterol Hepatol,2009,21(6) :606-612.
6Ferlay J,Bray F,Pisani P,Parkin DM.GLOBOCAN 2000:Cancer Incidence,Mortality and Prevalence Worldwide.Version 1.0.IARC Cancer Base No.5.Lyon:IARC Press,2001.
7Sipponen P,Kekki M,Haapakoski J,Ihamaki T,Siurala M.Gastric cancer risk in chronic atrophic gastritis:statistical calculations of cross-sectional data.Int J Cancer,1985,35:173～177.
8Koga M,Miyakawa K,Ikeda S.Annual Report of Gastroenterological Mass Survey in Japan,2002.Tokyo:Japanese Society of Gastroenterology Mass Survey.2004.
9Sipponen P,Ranta P,Helske T,Kaariainen I,Maki T,Linnala A,Suovaniemi O,Alanko A,Harkonen M.Serum levels of amidated gastrin-17 and pepsinogen Ⅰ in atrophic gastritis:an observational case-control study.Scand J Gastroenterol,2002,37:785～791.
10Sipponen P,Harkonen M,Alanko A,Suovaniemi O.Diagnosis of atrophic gastritis from a serum sample.Clin Lab,2002,48:505～515.
4Miki K, Morita M, Sasajima M, et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol, 2003, 98(4):735-739.
5Pomytkina TE. The serum content of gastrin-17 and pepsinogen-1 in patients with duodenal ulcerative disease in occupational contact with nitrogenous corn-pounds. Klin Lab Diagn, 2009(11):16-19.
7YADA T, ITO K, SUZUKI K, et al. Marked decrease in serum pepsinogen Ⅱ levels resulting from endoscopic resection of a large duodenal tumor[J]. Clin J Gastroenterol, 2014, 7(6): 484-489.
8KIM HJ, HWANG SW, KIM N, et al. Helicobacter pylori and molecular markers as prognostic indicators for gastric cancer in Korea[J]. Cancer Prey, 2014, 19(1): 56-67.
9NEJADI-KELARIJANI F, ROSHANDEL G, SEMNANI S, et al. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran[J]. Asian Pac J Cancer Prey, 2014, 15(17): 7433- 7436.
10KIM HJ, HWANG SW, KIM N, et al. Helicobacter pylori and molecular markers as prognostic indicators for gastric cancer in Korea[J]. Cancer Prey, 2014, 19(1):56-67.
